News
Shares of Gilead Sciences Inc. GILD slid 3.09% to $103.25 Thursday, on what proved to be an all-around favorable trading ...
Shares of Gilead Sciences Inc. GILD rallied 2.24% to $106.54 Wednesday, on what proved to be an all-around favorable trading ...
2d
Zacks Investment Research on MSNIs Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...
As the Trump administration stares down diversity programs, this big Peninsula employer is highlighting its efforts.
Carter Gould; Analyst; Cantor Fitzgerald & Co., Inc. James Shin ... are available on the Investors section of our website at gilead.com. The speakers on today's call will be our Chairman and ...
Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Assembly Biosciences, Inc.’s ASMB share price has surged by 5.74%, which has investors questioning if this is right time to ...
Below is Validea's guru fundamental report for GILEAD SCIENCES INC (GILD). Of the 22 guru strategies we follow, GILD rates highest using our Twin Momentum Investor model based on the published ...
FOSTER CITY, Calif., April 24, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its first quarter 2025 results of operations. FOSTER CITY, Calif., April 21 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results